TRALI Mitigation Policy
TRALI Mitigation Policy
Red Cell Contamination in Platelets and Apheresis Granulocytes
Red Cell Contamination in Platelets and Apheresis Granulocytes
Blood Use Optimization
Choosing Wisely Campaign: AABB List of Recommendations to Optimize Blood Use (Posted with permission from AABB.)
Bacterial Detection QC for Platelets
Bacterial Detection Quality Control for Platelets
Babesia microti Testing for Blood Collected in High-risk Endemic States
Babesia microti Testing for Blood Collected in High-risk Endemic States
Suspected Platelet Refractory State
Evaluation of the Patient with Suspected Platelet Refractory State (Physician's Guide)
Compliance Alert, January 2013: Important Information for All Laboratories
Compliance Alert, January 2013: Important Information for All Laboratories
Rationale for Universal Leukoreduction (ULR)
Rationale for Universal Leukoreduction (ULR)
Reintroduction of Nonleukoreduced Blood Components
Commentary on the safety of the reintroduction of nonleukoreduced blood components in hospitals that previously implemented universal leukoreduction (Transfusion, 2011)
NAT in Blood Screening Around the World
NAT in Blood Screening Around the World by Frank Strobl, MD, PhD